Zhejiang Sunflower board nominates Wu Junhua as non-independent director

Zhejiang Sunflower Great Health Technology Co., Ltd. (the company) convened its twelfth meeting of the sixth session of the board of directors on December 9, 2025. The meeting, chaired by Mr. Wu Shaoqin, saw all seven directors in attendance, with senior management also present. The board unanimously approved the nomination of Ms. Wu Junhua as a non-independent director candidate for the sixth session, following approval by the board's nomination committee. Her term will commence upon approval by the shareholders' meeting and will continue until the expiration of the sixth session's term.

If elected, Ms. Wu Junhua will also serve on the company’s Sixth Session Strategy Committee, Audit Committee, and Remuneration and Assessment Committee. This appointment would ensure that the number of directors who also hold senior management positions does not exceed one-half of the total number of directors on the board. The resolution received 7 votes in favor, 0 against, and 0 abstentions.

The board also resolved to hold the second extraordinary general meeting of 2025 on December 25, 2025, at 14:30 in the company's fifth-floor meeting room. This meeting will consider the aforementioned director appointment, with full details available on the China Securities Regulatory Commission's designated information disclosure website. This resolution also passed with 7 votes in favor, 0 against, and 0 abstentions.